Pharmacokinetics of Zoledronic Acid in Patients on Dialysis

NCT07741136 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Chronic Kidney Disease
Osteoporosis
Dialysis

Interventions

DRUG: Zoledronic Acid Injection, 5.0 mg, single dose
DRUG: Zoledronic Acid Injection, 2.5 mg, single dose
DRUG: Zoledronic Acid Injection, 5.0 mg, single dose

Sponsor

University of Campinas, Brazil

Collaborators

[object Object]